Home » Clinical Trials » Therapeutic Areas
Therapeutic Areas: Pediatrics/Neonatology | Pulmonary/Respiratory Diseases | Family Medicine
Disease Category: Asthma (Pediatric)
Location: United States, TX
Pediatric Asthma Study
The CHASE 2 Study is looking at the effectiveness and safety of different doses of a study medication in treating asthma in children. The study medication, formoterol, must always be given in combination with another medication called budesonide, which is an asthma preventer medicine. All children in this study will receive budesonide. Both formoterol and budesonide are well-known medicines which have been used to treat asthma in adults for many years. Both study medications will be given through an aerosol inhaler. All children will also be given a fast-acting reliever medication which can be taken for their asthma symptoms if it becomes necessary.
Your child may be suitable to take part in the study if they:
- are between the ages of 6 and 11 years
- have been diagnosed with asthma
- have not been hospitalized for more than 24 hours or required emergency treatment for their asthma during the past 6 months.
Patient Exclusion Criteria:
- not diagnosed with Asthma
Allergy Asthma Research Institute
333 Londonderry Drive
Waco, TX 76712
Phone: 254-751-1144 option 11
If you would like to learn more about participating in this study, please send an email message using the form below.
DISCLAIMER: This site is run by CenterWatch, a publishing company that focuses on the
clinical trials industry. The information provided in this service is designed
to help patients find clinical trials that may be of interest to them, and to
help patients contact the centers conducting the research. CenterWatch is
neither promoting this research nor involved in conducting any of these